Changes in leadership of breast cancer research and treatment Marc E. Lippman Editorial 09 January 2011 Pages: 605 - 605
Endoscopic breast surgery: where are we now and what might the future hold for video-assisted breast surgery? Daniel Richard LeffRajiv VashishtAra Darzi Review 03 December 2010 Pages: 607 - 625
Triple negative breast cancer: unmet medical needs Sumanta Kumar PalBarrett H. ChildsMark Pegram Review 15 December 2010 Pages: 627 - 636
Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer Marcus SchmidtIlka Brigitte PetryJan G. Hengstler Preclinical study 30 March 2010 Pages: 637 - 646
Breast cancer prognostic markers in the post-genomic era Lajos PusztaiTakayuki Iwamoto Invited Commentary 13 May 2010 Pages: 647 - 650
Mutations and polymorphic BRCA variants transmission in breast cancer familial members Brunella PilatoMarianna MartinucciStefania Tommasi Preclinical study 30 March 2010 Pages: 651 - 657
Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells Stephen HiscoxPeter BarnfatherPeter Barrett-Lee Preclinical study 31 March 2010 Pages: 659 - 669
COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients Johanna G. H. van NesEsther M. de KruijfJohn M. S. Bartlett Preclinical Study 01 April 2010 Pages: 671 - 685
Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients Esther M. de KruijfJohanna G. H. van NesWilma E. Mesker Preclinical Study 02 April 2010 Pages: 687 - 696
Genomics, histopathology, and the tumor microenvironment: new relationship or old friends re-discovered? Daniel W. Visscher Invited Commentary 15 May 2010 Pages: 697 - 698
Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene Wei JinYang LiuZhi-ming Shao Preclinical study 03 April 2010 Pages: 699 - 713
Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes Xiao-Hua ZengZhou-Luo OuZhi-Ming Shao Preclinical study 06 April 2010 Pages: 715 - 727
Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern Katharina E. EffenbergerElin BorgenBjorn Naume Clinical trial 07 May 2010 Pages: 729 - 738
Disseminated tumor cells: the method is the message John W. Park Invited Commentary 11 August 2010 Pages: 739 - 740
Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability J. Michael DixonLorna RenshawLesley J. Fallowfield Clinical trial 07 September 2010 Pages: 741 - 749
One size does not fit all: quality of life during adjuvant aromatase inhibitor therapy N. Lynn HenryVered Stearns Invited Commentary 13 October 2010 Pages: 751 - 753
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies Henri RochéPierfranco ConteGabriel N. Hortobagyi Clinical trial 03 December 2010 Pages: 755 - 765
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy Dawn L. HershmanLouis H. WeimerKatherine D. Crew Clinical trial 03 December 2010 Pages: 767 - 774
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer Dino AmadoriRosella SilvestriniAngelo Paradiso Clinical trial 04 December 2010 Pages: 775 - 784
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer Takayuki IwamotoGiampaolo BianchiniNaoto T. Ueno Clinical trial 09 December 2010 Pages: 785 - 795
Evaluation of estrogen and progesterone receptors in non-neoplastic breast tissue of women of reproductive age exposed to tamoxifen and raloxifene: a randomized, double-blind study Marta Alves RosalBenedito Borges da Silva Clinical trial 24 December 2010 Pages: 797 - 801
Outcomes following local therapy for early-stage breast cancer in non-trial populations Nancy L. KeatingMary Beth LandrumRita Volya Epidemiology 08 April 2010 Pages: 803 - 813
Supraclavicular recurrence after early breast cancer: a curable condition? Anders N. PedersenSusanne MøllerMichael Andersson Epidemiology 08 May 2010 Pages: 815 - 822
Breast cancer in the supraclavicular region: is the horse out of the barn? Reshma Jagsi Invited Commentary 28 July 2010 Pages: 823 - 825
RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies Lin-Bo GaoXin-Min PanLin Zhang Epidemiology 17 July 2010 Pages: 827 - 835
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers Victor R. GrannPriya R. PatelAlfred I. Neugut Epidemiology 20 July 2010 Pages: 837 - 847
Association of a vascular endothelial growth factor gene 936 C/T polymorphism with breast cancer risk: a meta-analysis Dae Sik YangKyong Hwa ParkJae Hong Seo Epidemiology 21 July 2010 Pages: 849 - 853
The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers Irene CatucciPaolo VerderioPaolo Peterlongo Epidemiology 22 July 2010 Pages: 855 - 860
Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes Madhura S. MehtaAlexei VazquezKim M. Hirshfield Epidemiology 25 July 2010 Pages: 861 - 868
Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study Daniel Prieto-AlhambraM. Kassim JavaidXavier Nogues Epidemiology 28 July 2010 Pages: 869 - 878
Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL® sample preparation C. C. TonN. VartanianP. L. Porter Brief Report 15 September 2010 Pages: 879 - 883
Two novel variants in the 3′UTR of the BRCA1 gene in familial breast and/or ovarian cancer Stéphanie LheureuxBernard LambertAgnès Hardouin Brief Report 17 September 2010 Pages: 885 - 891
A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance A. Gabriella WernickeRobert L. GoodmanK. S. Clifford Chao Brief Report 19 September 2010 Pages: 893 - 902
